Latest Patents News

Neuren says its partner Acadia has received a US Notice of Allowance for a trofinetide patent that could protect weight-banded dosing through 28 March 2041. The patent has not yet formally issued, but the allowance could extend US protection by almost five years beyond the existing method-of-use patent.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Cynata Therapeutics (ASX:CYP) has reported a $9.25 million loss, negative net assets and a material uncertainty over going concern after its two major clinical trials failed to demonstrate efficacy. The company has since cut its workforce to zero, shifted management to the board and secured a $600,000 R&D tax incentive loan while it considers the future of its Cymerus platform.

Perpetual Resources has warned of material uncertainty over its ability to continue as a going concern after its FY2026 loss more than tripled. The ASX-listed explorer finished the year with A$2.34 million in cash, but remains dependent on further capital raisings to fund Nevada Scheelite and Brazilian exploration.

Volt Group delivered a steep lift in HY26 revenue, adjusted EBITDA, profit and operating cash flow, with the 4D Delta acquisition providing the largest contribution. The mining technology company also expanded its Westgold solar-lighting fleet and advanced Wescone’s crusher technology.

Adisyn has moved closer to commercialising its graphene platform after independently verified sub-300°C deposition, a US patent allowance and a new defence technology arm. The progress came alongside a A$7.83 million statutory loss, A$4.47 million in operating cash outflows and a heavily judgement-based A$42.1 million technology asset.

Saferoads Holdings Limited (ASX:SRH) returned to profit in FY2026 after product sales more than doubled, helped by $5.18 million of purchases from On-Site Rental Group. The result marks progress after the Road Safety Rentals disposal, but the next test is whether growth can continue without a repeat commitment from its largest customer.

Perpetual Resources has added 62 lode claims around its Nevada Scheelite tungsten project, expanding the land position by 1,271.63 acres and more than 15 times the original patented claim area. The move broadens the project from a historic mine redevelopment opportunity into a larger exploration play, although the new ground remains untested.

Biome Australia Limited (ASX:BIO) delivered its second consecutive profitable year in FY26, with revenue rising 30% to $23.9 million and operating cash flow turning positive. But the headline $3.6 million profit includes a $2.4 million deferred tax benefit, leaving FY27 execution as the real test of the company’s growth plan.

TG Metals has strengthened its gold and lithium resource base, but the annual report carries a material uncertainty over its ability to continue as a going concern. The company ended June with $641,906 in cash, before securing a further $2.5 million placement after year end.

Olympio Metals has started a roughly 1,500-metre maiden diamond drilling program at its Jacknife silver project in Idaho, targeting mineralisation linked to more than 3.2 million ounces of historical silver production. The campaign is significant, but the company must still verify old data before it can establish a JORC-compliant resource.

ION Video has secured an oversubscribed $4.25 million placement to fund independent trials of its video technology, with directors and management committing a further $1.2 million subject to shareholder approval. The capital will be used to test whether ION’s architecture can deliver measurable technical and financial benefits in real operating environments.